ACM
BSX icon

Advisors Capital Management’s Boston Scientific BSX Stock Holding History

Advisors Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$336K Buy
7,868
+1,934
+33% +$105K ﹤0.01% 506
2026
Q1 		$372K Sell
5,934
-538
-8% -$43K ﹤0.01% 448
2025
Q4 		$617K Buy
6,472
+176
+3% +$17.3K 0.01% 365
2025
Q3 		$615K Sell
6,296
-150
-2% -$15.5K 0.01% 359
2025
Q2 		$692K Buy
6,446
+2,046
+47% +$207K 0.01% 326
2025
Q1 		$444K Buy
4,400
+948
+27% +$95.5K 0.01% 383
2024
Q4 		$308K Buy
3,452
+371
+12% +$32.7K ﹤0.01% 443
2024
Q3 		$258K Buy
3,081
+370
+14% +$29.2K ﹤0.01% 452
2024
Q2 		$209K Buy
+2,711
New +$198K ﹤0.01% 465
2020
Q2 		– Sell
-35,094
Closed -$1.15M – 300
2020
Q1 		$1.15M Sell
35,094
-37,534
-52% -$1.47M 0.07% 166
2019
Q4 		$3.28M Buy
+72,628
New +$3.04M 0.15% 146

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Advisors Capital Management's BSX Position: Q2 2026 in Review

Advisors Capital Management increased its Boston Scientific (BSX) stake by 33% in Q2 2026, buying an estimated $105K and bringing the position to 7,868 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #506.

Advisors Capital Management first reported a position in BSX in Q4 2019 and has held it in 11 quarters since. The position peaked at $3.28M in Q4 2019. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Advisors Capital Management held 7,868 shares of Boston Scientific worth $336K as of Q2 2026.
  • Advisors Capital Management bought 1,934 Boston Scientific shares in Q2 2026, an estimated $105K.
  • Boston Scientific made up ﹤0.01% of Advisors Capital Management's portfolio in Q2 2026, its #506 holding.
  • Advisors Capital Management first reported a position in Boston Scientific in Q4 2019 and has held it in 11 quarters since.
  • Advisors Capital Management's Boston Scientific position peaked at $3.28M in Q4 2019.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Advisors Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.